Eliglustat

Eliglustat Impurities

Eliglustat is a glucosylceramide synthase inhibitor that is generally used in the treatment of Gaucher disease type 1. Its impurity profile includes structurally related analogs, residual solvents, and degradation products. These pharmaceutical impurities can be formed under stress conditions such as hydrolysis, oxidation, and photolysis. Typical degradation pathways involve oxidative breakdown of the aromatic moieties, hydrolytic cleavage of amide bonds, and rearrangement of substituents within the heteroaromatic scaffold. These impurities may affect the potency, stability, and safety of the drug. Thus, all impurities must be structurally characterized and qualified according to ICH guidelines for toxicological assessment and analytical validation.

Eliglustat EP Impurities

We provide the pharmacopeial and non-pharmacopeial Eliglustat impurity compounds that are available in compliance with European Pharmacopoeia (EP) specifications. These standards support analytical method development, impurity profiling, and long-term stability studies. EP traceable materials are supplied with validated analytical data, including purity, structural confirmation, and spectral characterization.

Eliglustat Related Compounds

Structurally related compounds and synthetic analogs of Eliglustat are included for impurity identification, toxicological qualification, and regulatory submission. These related substances are used in forced degradation studies, genotoxicity assessments, and impurity threshold evaluations. They are essential for understanding the impurity profile and ensuring compliance with regulatory limits.

Eliglustat Impurity Reference Standards

We also supply the Eliglustat impurity reference standards, which are available with validated analytical data, including purity, NMR, MS, and full Certificates of Analysis. These standards are used in pharmaceutical research, method validation, and GMP-compliant quality control. The EP/USP traceable entries are available upon request and are routinely re-tested to ensure consistency and reliability.